Dyne Therapeutics, Inc. DYN Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dyne Therapeutics, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dyne Therapeutics, Inc.'s investing cash flow?
- Dyne Therapeutics, Inc. (DYN) reported investing cash flow of -$2.39M in Q1 2026.
- How has Dyne Therapeutics, Inc.'s investing cash flow changed year-over-year?
- Dyne Therapeutics, Inc.'s investing cash flow decreased by 264.1% year-over-year, from $1.46M to -$2.39M.
- What is the long-term trend for Dyne Therapeutics, Inc.'s investing cash flow?
- Over 4 years (2021 to 2025), Dyne Therapeutics, Inc.'s investing cash flow has grown at a -31.9% compound annual growth rate (CAGR), from -$137.89M to -$29.73M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.